Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2. (2023)
Attributed to:
The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi-generation, longitudinal resource
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.170681
PubMed Identifier: 37338994
Publication URI: http://europepmc.org/abstract/MED/37338994
Type: Journal Article/Review
Volume: 8
Parent Publication: JCI insight
Issue: 15
ISSN: 2379-3708